-
10861
-
10862
National Interhospital Transfer for Patients With Acute Cardiovascular Conditions
Published 2020-11-01Get full text
Article -
10863
Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis
Published 2019-01-01Get full text
Article -
10864
-
10865
-
10866
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
Published 2023-01-01Get full text
Article -
10867
Lidocaine for Neuropathic Cancer Pain (LiCPain): study protocol for a mixed-methods pilot study
Published 2023-02-01Get full text
Article -
10868
Neuroimaging in Functional Neurological Disorder: State of the Field and Research Agenda
Published 2021-01-01Get full text
Article -
10869
-
10870
-
10871
-
10872
-
10873
Characteristics of Post-ICU and Post-COVID Recovery Clinics in 29 U.S. Health Systems
Published 2022-03-01Get full text
Article -
10874
-
10875
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
Published 2017“…Reference lists and conference proceedings of major gastroenterology meetings were also handsearched to identify additional studies.Placebo-controlled RCTs of adult patients with UC treated with corticosteroids, aminosalicylates, immunosuppressives or biologics were eligible, provided enrolment and outcome assessment was conducted using the Ulcerative Colitis Disease Activity Index (UCDAI) or the Mayo Clinic Score. The minimum trial duration was two weeks for induction trials and four months maintenance trials.Pairs of authors independently determined study eligibility and extracted data with any disagreements resolved through consensus. …”
Journal article -
10876
-
10877
-
10878
World Congress Integrative Medicine & Health 2017: part two
Published 2017-06-01Get full text
Article -
10879
HLA in isolated REM sleep behavior disorder and Lewy body dementia
Published 2023-09-01Get full text
Article -
10880